NasdaqCM - Nasdaq Real Time Price USD

Gelteq Limited (GELS)

0.4901 -0.0159 (-3.14%)

At close: October 30 at 4:00:01 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?

Simply Wall St. 24d ago

GELS
-3.14%
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

GlobeNewswire 4mo ago

GELS
-3.14%
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

GlobeNewswire 5mo ago

GELS
-3.14%
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

GlobeNewswire 5mo ago

GELS
-3.14%
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

GlobeNewswire 4mo ago

GELS
-3.14%
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

ACCESS Newswire 5mo ago

HYEX

GELS
-3.14%
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

GlobeNewswire 4mo ago

GELS
-3.14%
Q1 Virtual Investor Summit Presentations Now Available On Demand

ACCESS Newswire 7mo ago
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

ACCESS Newswire 7mo ago
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

GlobeNewswire 8mo ago

GELS
-3.14%
HYEX
Gelteq announces preclinical results on medicinal cannabinoid absorption

TipRanks 9mo ago

GELS
-3.14%
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

GlobeNewswire 10mo ago

GELS
-3.14%

Performance Overview

Return	GELS	S&P 500 (^GSPC)
YTD	-38.74%	+10.73%
1-Year	-58.11%	+11.11%
3-Year	-87.75%	+81.91%

U.S. markets open in 42m

Gelteq Limited (GELS)

Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Q1 Virtual Investor Summit Presentations Now Available On Demand

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

Gelteq announces preclinical results on medicinal cannabinoid absorption

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China